Navigation Links
Quest Diagnostics Again Named to FORTUNE Magazine's 'World's Most Admired Companies' List
Date:3/3/2009

Ranks second overall and first for long-term investment and social responsibility in industry category

MADISON, N.J., March 3 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, has again been named to FORTUNE magazine's list of the World's Most Admired Companies. Quest Diagnostics ranked second in the "Health Care" category of "Pharmacy and Other Services." The 2009 ranking is the second consecutive year that the company has been included on FORTUNE's Most Admired Companies list. The company advanced to second place from third in 2008. The new World's Most Admired Companies list is widely considered the definitive report card on corporate reputations.

"This prestigious recognition reflects the dedicated efforts of our 43,000 employees to put patients first and provide superior diagnostic services," said Surya N. Mohapatra, Ph.D., Chairman and CEO of Quest Diagnostics. "We are particularly gratified to have ranked number one in our industry category for long-term investment, which demonstrates support for our strategy and vision."

FORTUNE's list of the World's Most Admired Companies is based on surveys of more than 4,000 executives, directors and securities analysts of companies they admire most in their industry based on nine criteria: innovation, people management, use of corporate assets, quality of management; social responsibility; financial soundness, long-term investment, quality of products and services, and global competitiveness. For 2009, FORTUNE published one list rather than separate World's Most Admired and America's Most Admired lists in order to better represent the competitive landscape faced by today's companies.

The full list and related stories appear in the March 16 issue of FORTUNE, available on newsstands on Monday, March 9th, and now at: http://money.cnn.com/magazines/fortune/mostadmired/2009/index.html

About Quest Diagnostics

Quest Diagnostics is the world's leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Additional company information is available at www.questdiagnostics.com.

The statements in this press release that are not historical facts or information may be forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause actual results and outcomes to be materially different. Certain of these risks and uncertainties may include, but are not limited to, competitive environment, changes in government regulations, changing relationships with customers, payers, suppliers and strategic partners and other factors described in the Quest Diagnostics Incorporated 2007 Form 10-K and subsequent SEC filings.


'/>"/>
SOURCE Quest Diagnostics Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. FRC Action Questions President Obamas Choice of Gov. Sebelius for HHS
2. Presidents 2010 Budget Request Strongly Supports VA Programs
3. An Athletes First Question: Doc, When Can I Return?
4. Six Questions Consumers Should Ask About Genetic Tests
5. Virtual studies answer real questions
6. Findings raise new questions about evolution of hormones in mammals
7. Charleston Conducts Evaluation of an Opioid Symptoms Questionnaire
8. C4CC Education Fund Launches Discussion Forum for Consumers With Health Insurance Questions
9. SurgiQuest Announces FDA Approval for Smoke & Plume Evacuation for AirSeal Dynamic Pressure System(TM)
10. Study questions effectiveness of $80 million per year brain exercise products industry
11. ANA and ISONG Co-Publish Genetics and Ethics in Health Care: New Questions in the Age of Genomic Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2016)... ... February 13, 2016 , ... When an Au Pair comes all the ... what they are in for and they are often worried things won’t go well. More ... hoping for. This year’s Au Pair of the Year winner’s all commented how their Au ...
(Date:2/12/2016)... ... 12, 2016 , ... The law firm of Morrow, Morrow, Ryan & Bassett ... of these scholarships is to encourage applicants to pursue a degree in their field ... two parishes. , “We have available jobs in St. Landry and Evangeline Parishes ...
(Date:2/12/2016)... ... February 12, 2016 , ... Each year, the American Physical Therapy ... Anaheim, CA at the Anaheim Convention Center. Almost 10,000 physical therapists across the country ... in action, learn more about their chosen field and network with their colleagues. ...
(Date:2/12/2016)... ... February 12, 2016 , ... Itopia, a ... the integration of Clarity Intelligence Platform (CIP) into Cielo®, a discovery, migration and ... intelligence (BI) to their small and medium business (SMB) clients. , ...
(Date:2/12/2016)... ... ... Vail knee specialist Robert LaPrade, MD, PhD was named one ... consists of physicians establishing, leading and partnering with ambulatory surgery centers across the United ... Center, also known as an ASC, is a modern health care facility focused on ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... ALEXANDRIA, Va. , Feb. 12, 2016  This ... & Specialty Pharmacy (JMCP) takes an in-depth look ... the recent spike in prescription drug spending, which has ... JMCP Editor-in-Chief Laura E. Happe ... Laura E. Happe , PharmD, MPH. --> ...
(Date:2/12/2016)... , February 12, 2016 ... anders vermerkt)   http://www.sedar.com ) ... http://www.telestatherapeutics.com abrufbar.    --> ... Unternehmens http://www.telestatherapeutics.com abrufbar.    ... PNK:BNHLF) veröffentlichte heute seinen Konzernabschluss des zweiten ...
(Date:2/12/2016)... 2016  Sequent Medical, Inc. announced today that it ... the safety and effectiveness of the WEB™ Aneurysm Embolization ... aneurysms.  Prof Laurent Spelle , MD, Head of ... France and Principal Investigator of the CLARYS ... and Germany.  Although patients with ruptured aneurysms ...
Breaking Medicine Technology: